Circadian rhythmicity as a predictor of quality of life in allogeneic hematopoietic cell transplant patients

Quality of life is increasingly recognized as an important outcome of cancer treatment. Previous studies have examined clinical predictors of quality of life, but with the increasing prevalence of wearable sensors that monitor sleep and activity patterns, further investigation into whether these behaviors are predictive of post-treatment quality of life is now feasible. Among patients receiving aggressive cancer treatment such as hematopoietic cell transplantation (HCT), analysis of circadian rhythms (24-hour patterns of sleep and activity) via wearable sensors is limited.

http://bit.ly/2DMkzel